Public comment periods in the registry — page 2
120 documents of type public comment period.
Documents
-
Consultation on the draft of this scoping review, which registers the question: What clinical evidence supports the uses under which growth-hormone secretagogues are…
13 Jan 2026 -
Consultation on the draft safety review of delayed gastric emptying and residual gastric content in patients receiving an incretin receptor agonist who present for…
26 Dec 2025 -
Consultation on the draft of this analytical evidence review, which registers the question: What proportion of certificates of analysis supplied with research peptides…
12 Dec 2025 -
Consultation on the draft standard for bacterial endotoxin testing of peptide presentations, which specifies the performance a determination must achieve and the…
23 Nov 2025 -
Consultation on the draft monograph for Ipamorelin, which the assessment committee released for public comment before ratification. The draft grades the compound's…
23 Nov 2025 -
Consultation on the draft synthesis of weight trajectory after an incretin receptor agonist is stopped. The contributing evidence is drawn principally from the…
05 Nov 2025 -
Consultation on the draft monograph for Thymalin, which the assessment committee released for public comment before ratification. The draft grades the compound's…
25 Oct 2025 -
Consultation on the draft monograph for CagriSema (cagrilintide with semaglutide), which the assessment committee released for public comment before ratification. The…
22 Oct 2025 -
Consultation on the draft monograph for Semax, which the assessment committee released for public comment before ratification. The draft grades the compound's principal…
14 Oct 2025 -
Consultation on the draft monograph for NAD+ (nicotinamide adenine dinucleotide), which the assessment committee released for public comment before ratification. The…
29 Sep 2025 -
Consultation on the draft of CEI-MS-12, which specifies the performance a determination must achieve for content and states what the resulting figure does not establish…
29 Sep 2025 -
Consultation on the draft monograph for Tesamorelin, which the assessment committee released for public comment before ratification. The draft grades the compound's…
28 Sep 2025 -
Consultation on the draft analytical evidence review of published surveys of unregulated peptide supply. The review assesses what such surveys establish, and records…
24 Sep 2025 -
Consultation on the draft monograph for danuglipron, an oral non-peptide glucagon-like peptide-1 receptor agonist whose development programme was discontinued. The draft…
16 Sep 2025 -
Consultation on the draft monograph for DSIP, which the assessment committee released for public comment before ratification. The draft grades the compound's principal…
14 Sep 2025 -
Consultation on the draft monograph for Liraglutide, which the assessment committee released for public comment before ratification. The draft grades the compound's…
06 Sep 2025 -
Consultation on the second version of the tirzepatide monograph, which incorporates the obesity evidence from SURMOUNT-1, reported in the New England Journal of Medicine…
02 Jul 2025 -
Consultation on the draft of CEI-MS-09, which specifies the performance a determination must achieve for physical quality and states what the resulting figure does not…
24 Jun 2025 -
Consultation on the draft monograph for Selank, which the assessment committee released for public comment before ratification. The draft grades the compound's principal…
22 Jun 2025 -
Consultation on the draft safety review of the rodent thyroid C-cell signal observed with glucagon-like peptide-1 receptor agonists and its relevance to humans. The…
13 Jun 2025 -
Consultation on the comparison table that presents supplier dossiers side by side. The draft table shows only fields verified from a document the Institute holds, and…
10 Jun 2025 -
Consultation on the draft of this methodological review, which registers the question: To what extent does a change in body weight predict a change in the clinical…
03 Jun 2025 -
Consultation on the draft monograph for TB-500, which the assessment committee released for public comment before ratification. The draft grades the compound's principal…
22 May 2025 -
Consultation on the print and archival format for Institute documents: what a printed copy must carry so that it remains checkable when detached from the site, and what…
02 May 2025 -
Consultation on the terms governing the Institute's calculators. The draft states that a calculator implements a published formula, that it holds no user data, and that…
01 May 2025 -
Consultation on the draft of this scoping review, which registers the question: What randomised human evidence exists for BPC-157 in any indication?
22 Apr 2025 -
Consultation on the draft of this intervention review, which registers the question: In adults at elevated cardiovascular risk, what is the effect of a glucagon-like…
20 Apr 2025 -
Consultation on the draft of this intervention review, which registers the question: In adults with type 2 diabetes, does tirzepatide achieve greater glycaemic and…
16 Apr 2025 -
Consultation on the draft of CEI-MS-06, which specifies the performance a determination must achieve for microbiological quality and states what the resulting figure…
14 Apr 2025 -
Consultation on the third version of the semaglutide monograph. The revision incorporates the cardiovascular outcome evidence from SELECT, reported in the New England…
03 Apr 2025 -
Consultation on the draft monograph for GHRP-2, which the assessment committee released for public comment before ratification. The draft grades the compound's principal…
30 Mar 2025 -
Consultation on the draft of this safety review, which registers the question: What is the incidence of gastrointestinal adverse events and of discontinuation for…
29 Mar 2025 -
Consultation on the draft monograph for Dulaglutide, which the assessment committee released for public comment before ratification. The draft grades the compound's…
14 Mar 2025 -
Consultation on the draft monograph for GHK-Cu, which the assessment committee released for public comment before ratification. The draft grades the compound's principal…
27 Feb 2025 -
Consultation on the draft of this intervention review, which registers the question: In adults with type 2 diabetes and chronic kidney disease, what is the effect of a…
17 Jan 2025 -
Consultation on the search-strategy template used across the synthesis series: the databases searched, the structure of the strategy, the handling of registry records…
13 Jan 2025 -
Consultation on the structure of the document registry: the identifier scheme, the fields carried for every document, and the way a superseded document is represented…
10 Jan 2025 -
Consultation on the draft of this methodological review, which registers the question: For neuropeptides holding a national marketing registration outside the…
06 Jan 2025 -
Consultation on how the Institute should label a programme record it has constructed by grouping trials, as distinct from a programme as defined by its sponsor. The…
05 Jan 2025 -
Consultation on the draft of this safety review, which registers the question: Do incretin-based therapies increase the incidence of acute pancreatitis?
04 Jan 2025
page 2 of 3